Lipid‐Lowering Effect and Safety of Ezetimibe and Atorvastatin 5 mg in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia: A Randomized, Double‐Blind, Parallel, Multicenter, Phase 3 Clinical Trial

Documenti analoghi

• Impact of Atrial Fibrillation at the Time of Coronary Revascularization on Long‐Term Outcomes: From the G‐NUH Registry
  di: Jaemyoung Lee, et al.
  Pubblicazione: (2025)
• Prognostic Value of GRACE Score and Left Ventricular Ejection Fraction in Non‐ST‐Segment Elevation Myocardial Infarction
  di: Yong Hoon Kim, et al.
  Pubblicazione: (2025)
• Cardiovascular outcomes between dapagliflozin versus empagliflozin in patients with diabetes mellitus
  di: Jee‐Heon Kim, et al.
  Pubblicazione: (2024)
• Population‐Based Study on Epidemiological Trends in Interventions for Congenital Heart Disease in Korea Using Nationwide Big Data
  di: Jae Sung Son, et al.
  Pubblicazione: (2025)
• Application of Single Versus Double‐ProGlide Devices for Vascular Access Closure After Transfemoral Transcatheter Aortic Valve Implantation in Korean Patients
  di: Yangyoun Lee, et al.
  Pubblicazione: (2025)